Veterinary Medicines

Nobilis ND C2 lyophilisate for oculonasal suspension for chickens

Authorised
  • Newcastle disease virus, strain C2, Live
Download as PDF

Product identification

Medicine name:
Nobilis ND C2 lyophilisate for oculonasal suspension for chickens
Nobilis ND C2 liofilizat za okulonazalno suspenzijo za piščance
Active substance:
  • Newcastle disease virus, strain C2, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use
  • Nebulisation use

Product details

Active substance and strength:
  • Newcastle disease virus, strain C2, Live
    5.70
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • All relevant tissues
        no withdrawal period
  • Nebulisation use
    • Chicken
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Package description:
  • Available only in Slovenian
  • Available only in Slovenian
  • Available only in Slovenian
  • Available only in Slovenian
  • Available only in Slovenian
  • Available only in Slovenian
  • Available only in Slovenian
  • Available only in Slovenian
  • Available only in Slovenian
  • Available only in Slovenian
  • Cardboard box with 10 vials of 1000 doses.
  • Cardboard box with 10 vials of 10000 doses.
  • Cardboard box with 10 vials of 2500 doses.
  • Cardboard box with 10 vials of 25000 doses.
  • Cardboard box with 10 vials of 5000 doses.
  • Cardboard box with 10 vials of 500 doses.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • MR/V/0220/001
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0113/001
Concerned member states:
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 12/11/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 12/11/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 12/11/2025
Download

Combined File of all Documents

English (PDF)
Published on: 8/10/2025
Download